A Critical Role for Eosinophils in Allergic Airways Remodeling

Features of chronic asthma include airway hyperresponsiveness, inflammatory infiltrates, and structural changes in the airways, termed remodeling. The contribution of eosinophils, cells associated with asthma and allergy, remains to be established. We show that in mice with a total ablation of the eosinophil lineage, increases in airway hyperresponsiveness and mucus secretion were similar to those observed in wild-type mice, but eosinophil-deficient mice were significantly protected from peribronchiolar collagen deposition and increases in airway smooth muscle. These data suggest that eosinophils contribute substantially to airway remodeling but are not obligatory for allergen-induced lung dysfunction, and support an important role for eosinophil-targeted therapies in chronic asthma.

[1]  D. Friend,et al.  Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2]  H. Chapman.  Disorders of lung matrix remodeling. , 2004, The Journal of clinical investigation.

[3]  D. Postma,et al.  ADAM33 gene: confirming a gene without linkage , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[4]  S. Phipps,et al.  Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. , 2003, The Journal of clinical investigation.

[5]  P. Weller,et al.  Eosinophils and cysteinyl leukotrienes. , 2003, Prostaglandins, leukotrienes, and essential fatty acids.

[6]  S. Orkin,et al.  GATA-1 as a Regulator of Mast Cell Differentiation Revealed by the Phenotype of the GATA-1low Mouse Mutant , 2003, The Journal of experimental medicine.

[7]  C. G. McVicker,et al.  Repeated allergen inhalation induces phenotypic modulation of smooth muscle in bronchioles of sensitized rats. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[8]  S. Orkin,et al.  Targeted Deletion of a High-Affinity GATA-binding Site in the GATA-1 Promoter Leads to Selective Loss of the Eosinophil Lineage In Vivo , 2002, The Journal of experimental medicine.

[9]  S. Sanjar,et al.  Airway subepithelial fibrosis in a murine model of atopic asthma: suppression by dexamethasone or anti-interleukin-5 antibody. , 2000, American journal of respiratory cell and molecular biology.

[10]  J Bousquet,et al.  Asthma. From bronchoconstriction to airways inflammation and remodeling. , 2000, American journal of respiratory and critical care medicine.

[11]  R. Homer,et al.  Airway remodeling in asthma. , 1999, The Journal of clinical investigation.

[12]  S. Wenzel,et al.  Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. , 1999, American journal of respiratory and critical care medicine.

[13]  W. Busse,et al.  Airway remodeling and repair. , 1999, American journal of respiratory and critical care medicine.

[14]  R. Homer,et al.  Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. , 1999, The Journal of clinical investigation.

[15]  R. Flavell,et al.  Expression of Interleukin 9 in the Lungs of  Transgenic Mice Causes Airway Inflammation, Mast Cell Hyperplasia, and Bronchial Hyperresponsiveness , 1998, The Journal of experimental medicine.

[16]  R. Martin,et al.  Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. , 1997, American journal of respiratory cell and molecular biology.

[17]  E. Gelfand,et al.  Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. , 1997, American journal of respiratory and critical care medicine.

[18]  J. Bousquet,et al.  Transforming Growth Factor- β Expression in Mucosal Biopsies in Asthma and Chronic Bronchitis , 1997 .

[19]  E. Gelfand,et al.  Interleukin-5 Expression in the Lung Epithelium of Transgenic Mice Leads to Pulmonary Changes Pathognomonic of Asthma , 1997, The Journal of experimental medicine.

[20]  M. Jordana,et al.  Transforming growth factor beta 1 (TGF beta 1) gene expression by eosinophils in asthmatic airway inflammation. , 1996, American journal of respiratory cell and molecular biology.

[21]  B. Stripp,et al.  Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[22]  G. Gleich,et al.  The biology of the eosinophilic leukocyte. , 1993, Annual review of medicine.

[23]  P. Howarth,et al.  Myofibroblasts and subepithelial fibrosis in bronchial asthma. , 1990, American journal of respiratory cell and molecular biology.

[24]  A. Wanner.  The role of mucus in chronic obstructive pulmonary disease. , 1990, Chest.

[25]  A. Wardlaw,et al.  Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. , 1989, The American review of respiratory disease.

[26]  J. Drazen,et al.  Pulmonary responses to bronchoconstrictor agonists in the mouse. , 1988, Journal of applied physiology.

[27]  W. Slidders,et al.  Studies on the character and staining of fibrin , 1962, Journal of clinical pathology.